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Formation of new blood vessels (angiogenesis) is a key step during the development of various pathologies, 
including cancer. Enzymes of the ADAMTS family are closely related to MMPs and ADAMs. They further 
contain specific domains, such as the "Thrombospondin type I" (TSP1) repeats, that are able to strongly repress 
angiogenesis, as described for thrombospondin-1 and -2, and for ADAMTS-1 and -8. The primary function of 
ADAMTS-2 is to process collagen type I, II and III precursors into mature molecules by excising the amino-
propeptide. We further hypothesized that it could modulate angiogenesis through its TSP1 repeats. This 
hypothesis was investigated using different in vitro experimental models of angiogenesis. Recombinant 
ADAMTS-2 induced morphological changes in human umbilical vein endothelial cells (HUVEC) and human 
microvessel endothelial cells (HMEC), and significantly reduced their proliferation, attachment and spreading. 
Similar effects were observed when using inactive ADAMTS-2 mutated at the Zn2+-binding catalytic site. 
ADAMTS-2 did not alter the initial steps of formation of capillary-like structures by HUVEC in vitro. However, 
these structures appeared much less stable and were more rapidly disrupted in presence of ADAMTS-2 than in 
control conditions. ADAMTS-2 was also tested in an ex vivo angiogenesis model using aortic rings from rats and 
mice, wild type or KO for ADAMTS-2. Outgrowth of capillaries was slightly increased from aortas of 
ADAMTS-2 KO mice (TS2-/-) as compared to aortas from control animals (TS2+/+), while addition of full size 
recombinant ADAMTS-2 reduced the formation of capillary structures from rat aortas, suggesting its anti-
angiogenic activity. Choroidal neovascularization induced in TS2+/+ or TS2-/- mice by LASER burns was used 
as in vivo model to confirm the in vitro and ex vivo results. Several genes involved in the healing and 
angiogenesis processes (fibrillar collagens, VEGF, TGF-beta and CTGF) were not differently regulated in 
TS2+/+ and TS2-/- mice at 5 days. 
